Decreased ovarian reserve and the number and quality of oocytes often occurs as the ovaries age and can cause fertility disorders and miscarriages. Researchers examined the relationship between thyroid-stimulating hormone levels and ovarian function.
Polycystic ovary syndrome is often linked with metabolic syndrome and other disorders, but researchers say current screening tools are inadequate. Researchers sought to discover more precise biomarkers to screen people for polycystic ovary syndrome.
Female surgeons are at increased risk for infertility and pregnancy complications.
The claims made on these websites establish these products as drugs under the Federal Food, Drug, and Cosmetic Act; however, none were evaluated by the FDA.
Black cohosh is a natural phytoestrogen product occasionally used in the management of PCOS-related infertility.
Study authors hypothesized that longer-acting testosterone replacement therapy will have significant impact on suppressing HPG axis compared with short-acting TRT preparations.
Combination therapy with insulin sensitizers may be superior to monotherapy for improvement of hyperandrogenemia and menstrual recovery in polycystic ovary syndrome.
Researchers examined factors associated with returning to the use of assisted reproductive therapy for a second child and cycle-specific and cumulative live birth rates.
Oocyte fatty acid composition differs between women with normal weight vs overweight or obesity and may be related to poor IVF outcomes.
Management of women at increased risk for hereditary gynecologic cancer must take into consideration concerns about fertility and hormonal health.
